A modified preparation (LMK03) of the oriental medicine Jangwonhwan reduces Abeta(1-42) level in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease.
Seo, Ji-Seon
A modified preparation (LMK03) of the oriental medicine Jangwonhwan reduces Abeta(1-42) level in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease. [electronic resource] - Journal of ethnopharmacology Aug 2010 - 578-85 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1872-7573
10.1016/j.jep.2010.05.055 doi
Alzheimer Disease--drug therapy
Amyloid beta-Peptides--drug effects
Angelica--chemistry
Animals
Brain--drug effects
Cell Line, Tumor
Disease Models, Animal
Female
Gene Expression Regulation--drug effects
Hippocampus--drug effects
Humans
Male
Medicine, East Asian Traditional
Mice
Mice, Transgenic
Neuroblastoma--drug therapy
Oxidative Stress--drug effects
Peptide Fragments--drug effects
Plant Extracts--pharmacology
Poria--chemistry
A modified preparation (LMK03) of the oriental medicine Jangwonhwan reduces Abeta(1-42) level in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease. [electronic resource] - Journal of ethnopharmacology Aug 2010 - 578-85 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1872-7573
10.1016/j.jep.2010.05.055 doi
Alzheimer Disease--drug therapy
Amyloid beta-Peptides--drug effects
Angelica--chemistry
Animals
Brain--drug effects
Cell Line, Tumor
Disease Models, Animal
Female
Gene Expression Regulation--drug effects
Hippocampus--drug effects
Humans
Male
Medicine, East Asian Traditional
Mice
Mice, Transgenic
Neuroblastoma--drug therapy
Oxidative Stress--drug effects
Peptide Fragments--drug effects
Plant Extracts--pharmacology
Poria--chemistry